Melanotan II enhances stress-induced anorexia and hypercortisolism in mice via brain melanocortin receptor activation
Background
The brain's melanocortin (MC) system is a well-established regulator of food intake and energy balance under normal, resting conditions. However, various forms of stress are known to potently inhibit appetite, a phenomenon known as stress-induced anorexia. While the link between stress and appetite loss is clear, the specific neural circuits mediating this response are not fully understood. It remains uncertain whether the same melanocortin pathways that control baseline feeding are also recruited to suppress food intake during stressful events. This study investigates if the central MC system is a key player in mediating the anorexic effects of acute stress in mice.
Study Design
C57Bl/6J male mice were fasted for 17 hours to pre-stimulate food intake. They were then subjected to acute ether stress (a 0.5-minute ether anesthesia exposure). Immediately following the stressor, mice received an intracerebroventricular (ICV) injection into the lateral brain ventricle. The three arms were: a control group receiving saline, a blockade group receiving the non-selective MC receptor antagonist SHU9119, and an activation group receiving the non-selective MC receptor agonist Melanotan II. Food intake was measured 1 hour post-stress. Plasma corticosterone levels and hypothalamic AgRP mRNA levels were also assessed at this time point.
Results
Ether stress alone significantly decreased food intake and increased plasma corticosterone levels 1 hour after exposure. The stress also elevated hypothalamic mRNA levels of AgRP, a natural antagonist of MC receptors. Pharmacological blockade of MC receptors with SHU9119 weakened the stress-induced anorexia, suggesting that endogenous melanocortin signaling is necessary for the full effect. This blockade also decreased the stress-induced rise in hypothalamic AgRP mRNA. Conversely, pharmacological stimulation of MC receptors with Melanotan II enhanced the anorexic effect of the ether stress.
The administration of Melanotan II also exacerbated the stress response itself, leading to significantly enhanced hypercortisolism (elevated plasma corticosterone) compared to stressed mice receiving only saline. This demonstrates a direct, causal link where central
melanocortinsystem activation not only suppresses appetite but also amplifies the physiological stress response.
Key Findings
- Ether stress decreased food intake and increased plasma corticosterone at 1 hour post-exposure.
- The MC receptor agonist Melanotan II enhanced ether stress-induced anorexia.
- Melanotan II also enhanced the stress-induced rise in plasma corticosterone (hypercortisolism).
- The MC receptor antagonist SHU9119 weakened stress-induced anorexia.
- Ether stress increased hypothalamic mRNA levels of the MC antagonist AgRP.
Why It Matters
These findings confirm that the central melanocortin system is a critical mediator of appetite suppression during acute stress. For users of Melanotan II, this implies that dosing during periods of high stress could significantly amplify both appetite suppression and the physiological stress response (as measured by cortisol). This suggests a potential for synergistic effects, where Melanotan II may make one more sensitive to the anorexic and cortisol-elevating effects of stress, or vice-versa. This interaction could be leveraged for enhanced appetite control but also warrants caution due to the potential for excessive cortisol elevation. The study highlights that the timing of administration relative to stressful events could be an important factor in managing the peptide's side effect profile and efficacy.
anorexia
appetite
stress
cortisol
melanocortin
animal study